SCHEMBL16774795

SCHEMBL16774795

COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(OCCN4CCCC4)cc3)ncn2)c1C

nearest known ligand 0.91

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 11/20 0.91
CYP3A4 P08684 6/20 0.91
FGFR1 P11362 8/20 0.63
LCK P06239 5/20 0.63
FGFR4 P22455 4/20 0.63
FGFR2 P21802 3/20 0.63
JAK2 O60674 2/20 0.63
ABL1 P00519 2/20 0.63
INSR P06213 2/20 0.63
FYN P06241 2/20 0.63
YES1 P07947 2/20 0.63
LYN P07948 2/20 0.63
RET P07949 2/20 0.63
MET P08581 2/20 0.63
ROS1 P08922 2/20 0.63
KIT P10721 2/20 0.63
SRC P12931 2/20 0.63
BRAF P15056 2/20 0.63
PDGFRA P16234 2/20 0.63
FLT1 P17948 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL374681 0.95 FGFR3 (1.00) FGFR3CYP3A4FGFR1LCKFGFR4
SCHEMBL4767225 0.95 FGFR3 (0.82) FGFR3CYP3A4FGFR1LCKFGFR4
SCHEMBL374374 0.90 FGFR3 (0.90) FGFR3CYP3A4FGFR1LCKFGFR4
SCHEMBL16774660 0.90 FGFR3 (0.74) FGFR3CYP3A4FGFR1LCKFGFR4
SCHEMBL2015731 0.89 FGFR3 (0.87) FGFR3CYP3A4FGFR1LCKFGFR4
SCHEMBL4763496 0.88 FGFR3 (0.70) FGFR3CYP3A4FGFR1LCKFGFR4
SCHEMBL374509 0.86 FGFR3 (0.83) FGFR3CYP3A4FGFR1LCKFGFR4
SCHEMBL377378 0.86 FGFR3 (0.83) FGFR3CYP3A4FGFR1LCKFGFR4
SCHEMBL2011654 0.84 FGFR3 (0.80) FGFR3CYP3A4FGFR1LCKFGFR4
SCHEMBL2012837 0.84 FGFR3 (0.65) FGFR3CYP3A4FGFR1LCKFGFR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1976847-B1 PYRIMIDINYL ARYL UREA DERIVATIVES BEING FGF INHIBITORS NOVARTIS AG (CH) 2015-06-17 EP claimed